Quick answers
- What is Droperidol used for?
- The FDA-approved label (Droperidol, American Regent, Inc., March 20, 2023) says: “Droperidol Injection is indicated to reduce the incidence of nausea and vomiting associated with surgical and diagnostic procedures.” This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.
- Does Droperidol have a boxed warning?
- Yes. The FDA label for Droperidol has a boxed warning, the FDA’s strongest warning. Read it on the full label and ask your pharmacist.
- Is there a shortage of Droperidol?
- No current shortage is listed by the FDA for the products of this medicine (FDA data from October 30, 2026).
- Has Droperidol been recalled?
- No recall linked to the products of this medicine appears in the FDA enforcement reports we use.
- Who makes Droperidol?
- 2 companies list prescription products of Droperidol in the FDA NDC Directory, including Hikma Pharmaceuticals USA Inc. and American Regent, Inc..
What Droperidol is used for
Quoted from the “Indications and Usage” section of the FDA-approved label.
Droperidol Injection is indicated to reduce the incidence of nausea and vomiting associated with surgical and diagnostic procedures.
— FDA label: Droperidol, American Regent, Inc., effective March 20, 2023. Read the full label on DailyMed →
The FDA has 2 labels for products of this medicine (different makers and forms); uses can differ between them. Check the label that comes with your own medicine.
This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.
Boxed warning
A boxed warning (“black box”) is the FDA’s strongest warning on a drug label, for serious or life-threatening risks.
This label has a boxed warning. Read it on the full label →
2 of 2 FDA labels for this medicine have a boxed warning.
Forms and how it is given
| Dosage forms | Injection, solution |
|---|---|
| Route | Intramuscular · Intravenous |
| Prescription products | 3 in the FDA NDC Directory |
Companies that list this medicine
Labelers in the FDA NDC Directory: the company named on the package (maker or distributor), with the number of prescription products.
- Hikma Pharmaceuticals USA Inc.2 products
- American Regent, Inc.1 product
FDA approval history
- ANDA: Abbreviated New Drug Application: how a generic version is approved.
Generic approvals (2)
- ANDA072123Am Regent · October 24, 1988
- ANDA208197Hikma · December 14, 2017
Shortage status
The FDA drug shortage list does not show these products.
Recalls
No recall linked to these products (by their NDC code) appears in the FDA enforcement reports.
Official identifiers
| RxCUI (RxNorm) | 282485, 2603284 |
|---|---|
| SPL set ID of the quoted label | 147e033d-d997-4ef6-8bb5-a9ba372590b2 |
| FDA labels (SPL) | 2 |
| FDA applications | 2 ANDA |
| Active ingredients (FDA) | DROPERIDOL |
Sources
- FDA-approved label on DailyMed (National Library of Medicine) — Droperidol, American Regent, Inc., effective March 20, 2023; via openFDA, FDA data exported October 30, 2026, retrieved October 31, 2026
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- Drug shortages (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
openFDA data is provided by the FDA as is; it may be incomplete. Always rely on the label that comes with your medicine. FDA Enforcement Report search →